1O'CONNER B J,AIKMAN S L,BARNES P J,et al.Tolerance to nonbronchodilator effects of inhaled beta 2-agnonists in asthma[J].New Engl J Med,1992,327(17):1204-1208.
2O'CONNER B J,FULLER R W,BARNES P J.Nonbronchodilator effects of inhaled beta 2-agnonists.Greater protection against adenosine monophosphate than methacholine induced brochoconstriction in asthma[J].Am J Respir Cirt Care Med,1994,150(2):381-387.
3REID D W,WARD C,WANG N,et al.Possible anti-inflammatory effect of salmeterol against interleukin-8 and neutrophil activation in asthma in vivo[J].Eur Respir J,2003,21(6):994-999.
4PINTO PEREIRA L M,CLEMENT Y,ROUSE J,et al.Salmeterol decreases eosinophilic cationic protein and rescue medication in patients inhaling beclomethasone dipropionate:preliminary study in mild and moderate asthma in Trinidad,West Indies[J].Int J Clin Pharmacol Res,2003,23(2-3):69-74.
5JANUARY B,SEBOLD A,ALLAL C,et al.Salmeterol-induced desensitization,internalization and phosphorylation of the human beta 2-adrenoceptor[J].Br J Pharmcol,1998,123(4):701-711.
6EICKELBERG O,ROTH M,LORX R,et al.Ligand-independent activation of the glucocortcoid receptor by β2-adrenergic receptor agnonists in primary human lung fibroblasts and vascular smooth muscle cells[J].J Biol Chem,1999,274(2):1005.
7NELSON H S,NATHAN R A,KALBERG C,et al.Comparision of inhaled salmeterol and oral zafirluhast in asthmatic patients using concomitant inhaled corticosteroids[J].Med Gen Med,2001,3(4):3.
8WALTERS E H,WALTERS J A E,GIBSON P W.Regular treatment with long acting beta agonists versus daily regular treatment with short acting beta agonists in adults and children with stable asthma[DB/CD]. Cochrane Batabase Syst Rev,2002.
9DONALD AM,JAMES FD,ROBERT AB,et al.Efficacy of salmenterol xinafoate in the treatment of COPD[J].Chest,1999,115(4):957-965.
10van VEEN A,WELLER F R,WIERENGA E A,et al.A comparison of salmeterol and formoterol in attenuating airway responses to short-acting beta 2-agonists[J].Pulm Pharmacol Ther,2003,16(3):153-161.
